VISTAGEN THERAPEUTICS, INC.

Transcripts Vistagen Therapeutics, Inc.

Equities

VTGN

US92840H4002

Real-time Estimate Cboe BZX Other stock markets 13:57:37 2024-05-10 EDT			5-day change	1st Jan Change
4.4 ^USD	-1.79%		-2.22%	-14.40%

04-25	Vistagen Announces Positive Results from Phase 2A Pilot Study of Ph15 for Improvement of Psychomotor Impairment Caused by Mental Fatigue	CI
04-01	Vistagen Initiates PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder Following Positive Results of PALISADE-2	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Vistagen Therapeutics, Inc., Q3 2024 Earnings Call, Feb 13, 2024	02-13
Transcript : Vistagen Therapeutics, Inc., Q2 2024 Earnings Call, Nov 09, 2023	11-09
Transcript : Vistagen Therapeutics, Inc., Q1 2024 Earnings Call, Aug 10, 2023	23-08-10
Transcript : Vistagen Therapeutics, Inc., 2023 Earnings Call, Jun 28, 2023	23-06-28
Transcript : VistaGen Therapeutics, Inc., Q3 2023 Earnings Call, Feb 07, 2023	23-02-07
Transcript : VistaGen Therapeutics, Inc., Q2 2023 Earnings Call, Nov 10, 2022	22-11-10
Transcript : VistaGen Therapeutics, Inc. Presents at Morgan Stanley 20th Annual Global Healthcare Conference, Sep-13-2022 11:45 AM	22-09-13
Transcript : VistaGen Therapeutics, Inc., Q1 2023 Earnings Call, Aug 11, 2022	22-08-11
Transcript : VistaGen Therapeutics, Inc., 2022 Earnings Call, Jun 23, 2022	22-06-23
Transcript : VistaGen Therapeutics, Inc., Q3 2022 Earnings Call, Feb 10, 2022	22-02-10

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Rankings

More Top / Flop

Rankings

More Top / Flop

Currency / Forex

Commodities

Cryptocurrencies

Cryptocurrencies

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW